Axogen, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Axogen, Inc. (AXGN) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$520.21 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-02
- Axogen, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$336.92K.
- Axogen, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$183.29K.
- Axogen, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$419.09K.
- Axogen, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$216.21K.
- Axogen, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.19M.
- Axogen, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$555.52K.
- Axogen, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$594.05K.
- Axogen, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$243.97K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$336.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$520.21K 10-Q · filed 2017-08-02 | -$939.30K derived: sum of 3 quarters · filed 2017-08-02 | -$1.16M derived: sum of 4 quarters · filed 2017-08-02 |
| 2017-03-31 | -$183.29K 10-Q · filed 2017-05-04 | -$602.38K derived: sum of 2 quarters · filed 2017-05-04 | -$818.59K derived: sum of 3 quarters · filed 2017-05-04 | -$884.50K derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-12-31 | -$419.09K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$635.30K derived: sum of 2 quarters · filed 2017-03-01 | -$701.21K derived: sum of 3 quarters · filed 2017-08-02 | -$1.19M 10-K · filed 2017-03-01 |
| 2016-09-30 | -$216.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$282.12K derived: sum of 2 quarters · filed 2017-08-02 | -$770.47K 10-Q · filed 2016-11-02 | -$880.71K derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-06-30 | -$65.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$554.25K 10-Q · filed 2017-08-02 | -$664.49K derived: sum of 3 quarters · filed 2017-08-02 | -$923.20K derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | -$488.34K 10-Q · filed 2017-05-04 | -$598.58K derived: sum of 2 quarters · filed 2017-05-04 | -$857.29K derived: sum of 3 quarters · filed 2017-05-04 | -$1.01M derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | -$110.24K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$368.95K derived: sum of 2 quarters · filed 2017-03-01 | -$517.18K derived: sum of 3 quarters · filed 2017-03-01 | -$555.52K 10-K · filed 2017-03-01 |
| 2015-09-30 | -$258.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$406.94K derived: sum of 2 quarters · filed 2016-11-02 | -$445.28K 10-Q · filed 2016-11-02 | -$657.00K derived: sum of 4 quarters · filed 2016-11-02 |
| 2015-06-30 | -$148.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$186.57K 10-Q · filed 2016-08-03 | -$398.29K derived: sum of 3 quarters · filed 2016-08-03 | -$466.83K derived: sum of 4 quarters · filed 2016-08-03 |
| 2015-03-31 | -$38.34K 10-Q · filed 2016-05-04 | -$250.06K derived: sum of 2 quarters · filed 2016-05-04 | -$318.61K derived: sum of 3 quarters · filed 2016-05-04 | -$428.56K derived: sum of 4 quarters · filed 2016-05-04 |
| 2014-12-31 | -$211.72K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$280.27K derived: sum of 2 quarters · filed 2016-02-29 | -$390.22K derived: sum of 3 quarters · filed 2016-02-29 | -$594.05K 10-K · filed 2016-02-29 |
| 2014-09-30 | -$68.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$178.50K derived: sum of 2 quarters · filed 2015-11-05 | -$382.33K 10-Q · filed 2015-11-05 | -$509.47K derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | -$109.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$313.78K 10-Q · filed 2015-08-06 | -$440.92K derived: sum of 3 quarters · filed 2015-08-06 | -$473.37K derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | -$203.83K 10-Q · filed 2015-05-05 | -$330.97K derived: sum of 2 quarters · filed 2015-05-05 | -$363.42K derived: sum of 3 quarters · filed 2015-05-05 | -$390.37K derived: sum of 4 quarters · filed 2015-05-05 |
| 2013-12-31 | -$127.14K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | -$159.59K derived: sum of 2 quarters · filed 2015-03-05 | -$186.54K derived: sum of 3 quarters · filed 2015-03-05 | -$243.97K 10-K · filed 2015-03-05 |
| 2013-09-30 | -$32.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$59.40K derived: sum of 2 quarters · filed 2014-11-13 | -$116.83K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | -$26.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$84.38K 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | -$57.42K 10-Q · filed 2014-04-30 | |||
| 2012-12-31 | -$127.28K 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |